AstraZeneca switches contractor as new headquarter delayed again

Drugmaker AstraZenecahas appointed a new construction manager to finish work on its new flagship headquarters in the English university city of Cambridge, following a series of delays and rising costs.Chief Executive Pascal Soriot has made the move to Cambridge a symbol of the group's renewed focus on cutting-edge science, but the building has faced a series of delays and the company said on Wednesday it did not now expect to occupy it until 2020.AstraZeneca had already warned in April 2017 that